All posts by: swiss

About swiss

Shahar Tsabari, M.D., presenting at the Swiss-Korean Life Science Symposium in Seoul

Seoul, South-Korea (October 23, 2015) Invited by the State Secretary for Education, Research and Innovation, Swiss Medendi is participating in the 2nd Swiss-Korean Life Science Symposium from October 21 to 23, 2015. Shahar Tsabari is presenting Swiss Medendi within the MedTech Start-up Pitching on Friday, October 23, in the JW Marriott Dongdaemoon in Seoul, Korea. … Continue reading

October 23, 2015 Uncategorized

Patent granted for Japan

Tokyo, Japan (October 5, 2015) Swiss Medendi’s patent has been granted by the Japan Patent Office. The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens the protection of Swiss Medendi’s intellectual property in Japan … Continue reading

October 5, 2015 Uncategorized

Patents granted for Eurasia

Moscow, Russia (October 5, 2015) Swiss Medendi’s patent, has been granted by the Eurasian Patent Organization (EAPO). The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens the protection of Swiss Medendi’s intellectual property in … Continue reading

October 5, 2015 Uncategorized

Patent granted for China

Beijing, China (July 26, 2015) Swiss Medendi’s patent,has been granted by the State Intellectual Property Office (SIPO) of the People’s Republic of China. The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens the protection … Continue reading

July 26, 2015

Patent granted for Mexico

Mexico City, Mexico (June 16, 2015) Swiss Medendi’s patent,  has been granted by the Mexican Patent Office, the Instituto Mexicano de la Propiedad Industrial (IMPI). The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. The patent strengthens … Continue reading

June 16, 2015

Swiss Medendi among the finalists in the StartCup Ticino

Lugano, Switzerland (December 04, 2014) Swiss Medendi succeeded in the semi-final of StartCup Ticino and was selected to participate in the StartCup Ticino final, competing against four other ventures for the Ticino StartCup 2014. About StartCup Ticino The StartCup Ticino competition is an initiative of the USI-SUPSI Start-Up Promotion Center (CP Start-Up) aiming at fostering … Continue reading

December 4, 2014

Winner of the W. A. de Vigier Award

Solothurn, Switzerland (June 14, 2014) Among more than 250 Swiss start-up companies, Swiss Medendi has won the prestigious W. A. de Vigier Award – endowed with CHF 100’000. The president of the W. A. de Vigier Foundation, Dr. Daniel Borer, highlighted Swiss Medendi as his personal favorite – not only because of his medical background … Continue reading

June 14, 2014

Shahar Tsabari, M.D., presenting at CTI Invest

Zurich, Switzerland (March 11, 2014) Shahar Tsabari, M.D., presents Swiss Medendi at CTI Invest on the Swiss Venture Day 2014. The Swiss Venture Day takes place in the SIX Swiss Exchange in Zurich, Switzerland. About CTI Invest CTI Invest is a private non-profit organization focused on the promotion of the Swiss venture landscape. Since its … Continue reading

March 11, 2014

Patent granted for Europe

EPO (December 18, 2013) Swiss Medendi’s patent, has been granted by the the European Patent Office (EPO). The patent covers the core technology of Swiss Medendi’s novel infusion device. The innovation was confirmed to fulfill all three patent criteria: Innovative, inventive, and commercially applicable. About Swiss Medendi Swiss Medendi SA is a Switzerland based start-up … Continue reading

December 18, 2013
  • 1
  • 2